
Chief Executive's Overview
In 2025, our transformation accelerated, with delivery at the top end of our guidance. The investments we have made in recent years are delivering tangible benefits, providing BAT with a stronger foundation for continued growth.
Tadeu Marroco
Chief Executive Officer

Chair’s Introduction
With our refined strategy as our north star, our transformation accelerated in 2025, underpinned by disciplined execution and resilience.
Luc Jobin
Chair

Interim Chief Financial Officer's Overview
We are steadfast in our commitment to deliver sustainable shareholder value by growing our New Categories and delivering value from combustibles, ensuring we maximise cash generation to fund our progressive dividend and sustainable share buy-backs.
Javed Iqbal
Interim Chief Financial Officer
Our Year in Numbers
A Better Tomorrow™ means Building a Smokeless World.
A Smokeless World built on Smokeless products, where, ultimately cigarettes have become a thing of the past.
A world where smokers, who would otherwise have continued to smoke, have migrated from cigarettes to smokeless alternatives.
A world where Tobacco Harm Reduction is both understood and accepted.
A world where smokers make a Switch to Better.
A refined purpose:
The best choice any adult smoker can make will always be quitting cigarettes completely.
Over the last few years, our aim has been to build A Better Tomorrow™. This means working to reduce the health impact of our business by offering adult consumers a greater choice of reduced-risk*† products compared to cigarettes.
Other than certain products within the Modern Oral category, BAT’s Smokeless products are not smoking cessation devices and are not marketed for that purpose.
Based on the weight of evidence and assuming a complete switch from cigarette smoking. These products are not risk free and are addictive.
Products sold in the U.S., including Vuse, Velo, Grizzly, Kodiak, and Camel Snus, are subject to FDA regulation and no reduced-risk claims will be made as to these products without agency clearance.
Vapers
Deserve
Better
Other than certain products within the Modern Oral category, BAT’s New Category products are not smoking cessation devices and are not marketed for that purpose.
Based on the weight of evidence and assuming a complete switch from cigarette smoking. These products are not risk free and are addictive.
Products sold in the U.S., including Vuse, Velo, Grizzly, Kodiak, and Camel Snus, are subject to FDA regulation and no reduced-risk claims will be made as to these products without agency clearance.
We know that the best choice any adult smoker can make is to quit completely. However, for those adults who would otherwise continue to smoke cigarettes, we believe that they should have the choice to switch completely to less risky*† alternative products – vaping being one of them.
Yet the future of vaping is at a crossroads, with threats from those who ignore regulations, design products that target the underaged, and disregard quality and product stewardship.
Not only does this negatively impact those trying to transition; it also lets vapers down. Vaping needs responsible leadership.
And that is why we launched our Vapers Deserve Better campaign in 2025.
Aimed at key policymakers, regulators and public health stakeholders, the campaign calls out practices that undermine responsible progress, while showing what leadership in Tobacco Harm Reduction should look like. It highlights BAT’s strengths in this space, while encouraging stakeholders to drive change, address societal concerns and ultimately, make a Smokeless World a reality.
Our Strategic Navigator
To achieve our ambitions and accelerate our transformation, we’re committed to Building a Smokeless World by deploying our global multicategory portfolio.
A Multi-Category Portfolio
These are our key brands in both the combustibles and Smokeless*† categories. This ensures focus and investment in the brands and categories that will underpin the Group’s future performance.

Our strategic portfolio
Smokeless:
All brands within New Categories (Vapour, Heated Products and Modern Oral) and the strategic Traditional Oral brands in moist and snus.
Combustibles:
Dunhill, Kent, Lucky Strike, Pall Mall, Rothmans, Newport (U.S.), Natural American Spirit (U.S.) and Camel (U.S.).
Modern Oral
49 markets
Modern Oral products are pouches that contain high-purity nicotine, water, and other high-quality ingredients. They are typically manufactured to be tobacco-leaf free. Consumers place the disposable pouch within the mouth, between the lip and gum, where nicotine and flavours are then released and absorbed.
Heated Products
29 markets
Heated Products (HPs) have two main functional parts: a battery-powered device and a consumable, which contains a plant-based (tobacco leaf or non-tobacco leaf) substance that is heated, not burned. Once the consumable has reached a certain temperature, it forms an aerosol releasing nicotine and flavours.
Traditional Oral
3 markets
Traditional Oral products include snus and snuff. Snus is a moist form of oral tobacco originating from Sweden. It is available in loose form or as pouches.
With Traditional Oral products, consumers take a single portion or pouch and place it within the mouth, between the lip and gum. The nicotine and flavours are then absorbed through the inner lining of the cheek.
Vapour
57 markets
Vapour products contain an e-liquid, nicotine and flavours, and a battery-powered heating element. When activated, via puff or button, the heating element heats the liquid and forms an aerosol, commonly known as vapour.
Combustibles
>140 markets
The Group sold 465 billion cigarette sticks and 12 billion other tobacco products (stick equivalents) in 2025. With 36 fully integrated cigarette manufacturing facilities in 35 markets, the Group operates internationally.
Other than certain products within the Modern Oral category, BAT’s New Category products are not smoking cessation devices and are not marketed for that purpose.
Based on the weight of evidence and assuming a complete switch from cigarette smoking. These products are not risk free and are addictive.
Products sold in the U.S., including Vuse, Velo, Grizzly, Kodiak, and Camel Snus, are subject to FDA regulation and no reduced-risk claims will be made as to these products without agency clearance.
Our Business at a Glance
Our Guiding Principles
Our purpose, vision and mission
We know A Better Tomorrow™ can be achieved by Building a Smokeless World. This is why we focus on offering adult consumers a choice of reduced-risk*† alternatives to cigarettes. This is complemented by our ambition to be a predominantly Smokeless business by 2035.
Where we operate
Our business is divided into three complementary regions, with a balanced presence in high-growth emerging markets and highly profitable developed markets. Each market is responsible for its own performance and driving growth.
Leading in Tobacco Harm Reduction
Through Omni™, our dynamic evidence-based manifesto and platform for change, BAT’s commitment to Tobacco Harm Reduction is not only clear, but founded in real-world evidence and supported by science. It presents a significant opportunity for stakeholders to join the conversation and drive change.
Working with key partners
We are collaborating with global leaders like BYD and Smoore to innovate and enhance our capabilities by leveraging expertise. We are also supporting world-class businesses through our venturing initiative, Btomorrow Ventures.
Three Complementary Regions
Note:
Map is accurate as at 31 December 2025 and is representative of general geographic regions and does not suggest that the Group operates in each country of every region.
Select a region to learn more
Top market by product
Combustibles
- Brazil
- Germany
- Mexico
- Romania
- Japan
- Pakistan
- U.S.
Heated Products
- Germany
- Greece
- Spain
- Italy
- Poland
- Romania
- Czech Republic
- Portugal
- Japan
- South Korea
Vapour
- Canada
- France
- Germany
- Poland
- Spain
- UK
- U.S.
Modern Oral
- Denmark
- Norway
- Sweden
- Switzerland
- Poland
- UK
- U.S.
Note: The Group also sells Traditional Oral in the U.S. and in AME.
Our Business Model
Our business model begins and ends with the consumer.
The insights we gather from adult consumers, backed by robust science, unlock value by ensuring we offer the right product choices to meet their preferences. Our product portfolio is constantly enhanced through innovations designed to better serve adult consumers and build A Better Tomorrow™. We use our international footprint to manufacture at speed and scale, and our global distribution capabilities to ensure our products are where they need to be, when needed, based on our market archetype model. Through our responsible marketing practices and powerful portfolio, we market and sell our products which, in turn, generate further insights.
Our business model is intrinsically connected to our value chain.
Principal Risks
-
1Competition from illicit trade
-
2Geopolitical tensions
-
3Tobacco, New Categories and other regulation interrupts growth strategy
-
4Supply chain disruption
-
5Litigation and external investigations
-
6Significant increases or structural changes in tobacco, nicotine and New Categories related taxes
-
7Inability to develop, commercialise and deliver the New Categories strategy
-
8Disputed taxes, interest and penalties
-
9Injury, illness or death in the workplace
-
10Solvency and liquidity
-
11Foreign exchange rates exposures
-
12Climate Change
-
13Circularity
-
14Digital & Cyber
Seeing over the horizon
As one of the most established tobacco and nicotine businesses in the world, we truly understand adult consumers and their diverse preferences. This, combined with our data and analytics-led approach, helps us to gain insights and anticipate trends.
These insights enable the development and responsible marketing of our products, so that they are fit to satisfy consumer preferences.
Powered by our consumer insights platform, we focus on product categories and consumer segments across our global business that have the greatest potential for sustainable growth.
Accelerating Tobacco Harm Reduction acceptance
We rely on world-class science to substantiate the product safety, quality and reduced-risk*† potential of our Smokeless products. It is crucial for building trust with consumers and regulators, and encouraging adult smokers – who would otherwise continue to smoke – to completely switch to less risky alternatives*†
Chemistry, molecular biology, and toxicology are just some of the fields that our extensive scientific research programme covers. We are transparent about our science and have published a compendium of information in the Omni™, which explores over a decade’s worth of Tobacco Harm Reduction evidence, alongside science and research.
Staying ahead of the curve
As consumer preferences and technology rapidly evolve, our international network of digital hubs, innovation hubs, world-class research and development (R&D) laboratories and external partnerships help us to stay at the forefront of innovation with our products, alongside our corporate venturing initiative, Btomorrow Ventures.
Innovation is core to us driving sustainable growth, and we invest significantly in R&D to create great products that satisfy changing consumer preferences. Led by data and consumer insights, each innovation takes us a step further towards building A Better Tomorrow™ by reducing the health impact of our business.
Sourcing materials responsibly
The majority of our tobacco is sourced by our Group-owned vertically integrated Leaf Operations through direct contracts with c.91,000 farmers. The remaining tobacco is sourced from third-party suppliers that, in turn, contract with an estimated 134,000 farmers. The vast majority of tobacco farms in our supply chain are smallholder family farms.
Beyond tobacco, we source product materials like paper and filters for cigarettes and, for our New Category products, we have a growing supply chain in consumer electronics and e-liquids. We also have a vast network of suppliers of indirect goods and services that support our business beyond our products, such as for IT services and facilities management.
Utilising our global manufacturing footprint
We manufacture high-quality products in our international facilities. These products, and the tobacco leaf we source, are then optimised for distribution and sale.
Our tobacco leaf may be processed upstream via our contracted farmers, and processing can also occur in our own Leaf Operation sites. Our Smokeless products are manufactured in a mix of our own and third-party factories. We work to keep our costs globally competitive and endeavour to use our resources as effectively as possible.
Technologies including AI and machine learning help us to get our products to the right place at the right time.
Our products are sold across the world and distributed efficiently using distribution models tailored to suit local circumstances and conditions. These include retailers, supplied through our direct distribution capability or exclusive distributors, and our Direct-to-Consumer business – which has been accelerated through the deployment of owned e-commerce sites.
We use a globally responsible approach to marketing, seeking to raise standards and prevent underage access, while growing our market share by encouraging adult consumers to choose our products over those of our competitors.
Our marketing across all our tobacco, nicotine and nicotine-free products and brands is governed by our Responsible Marketing Principles (RMP) and Responsible Marketing Code (RMC). They include strict requirements to be accurate, responsible, and targeted at adult consumers only. Our RMP are applied even when they are stricter than local laws.
Our powerful portfolio of brands is something we’re proud of – including our combustibles portfolio and our Smokeless product brands, which we believe will drive us towards our strategic aim. Our strong product pipeline is supported by our quality insights, science and innovation, and international positioning. We offer adult consumers all over the world a range of high-quality products – from value-for-money to premium, including combustible products, Vapour, Modern Oral, Traditional Oral and Heated Products.
We are proud of our powerful portfolio of brands. This includes our combustibles portfolio and our Smokeless product brands which we believe will accelerate us towards our strategic aim. Our product pipeline is strong, aided by our quality insights, science and innovation, and being well-positioned globally. We offer adult consumers all over the world a range of high-quality products – from value-for-money to premium, including combustible products, Vapour, Modern Oral and Heated Products.
Link to Principal Risks
Competition from illicit trade; Geopolitical tensions; Tobacco, New Categories and other regulation interrupts growth strategy; Supply Chain disruption; Litigation; Significant increases or structural changes in tobacco, nicotine and New Categories related taxes; Inability to develop, commercialise and deliver the New Categories strategy; Disputed taxes, interest and penalties; Foreign exchange rate exposures; Circular economy
Based on the weight of evidence and assuming a complete switch from cigarette smoking. These products are not risk free and are addictive.
Products sold in the U.S., including Vuse, Velo, Grizzly, Kodiak, and Camel Snus, are subject to FDA regulation and no reduced-risk claims will be made as to these products without agency clearance.
A Better Tomorrow™ for:
Adult consumers are at the core of everything we do and our success is underpinned by addressing their preferences, offering them a choice of enjoyable, innovative and less risky products*† .
Based on the weight of evidence and assuming a complete switch from cigarette smoking. These products are not risk free and are addictive.
Products sold in the U.S., including Vuse, Velo, Grizzly, Kodiak, and Camel Snus, are subject to FDA regulation and no reduced-risk claims will be made as to these products without agency clearance.
We employ 47,000+ people worldwide. Attracting and retaining an increasingly diverse workforce and providing a welcoming, inclusive working environment are key drivers in BAT’s transformation journey to build A Better Tomorrow™. Our focus is on providing a dynamic, inspiring and purposeful place to work.
Accredited as Global Top Employer by the Top Employers Institute
As at 31 December 2025. Refer to the BAT 'Reporting Criteria' for a full description of key terms and definitions bat.com/reporting

We work with a range of suppliers worldwide. Our suppliers across the Group are valued business partners and we believe, by working together, we can raise standards, drive sustainable practices, create shared value and build A Better Tomorrow™.

Our customers include retailers, distributors and wholesalers who are essential for driving growth and embedding responsible marketing practices.
We are committed to delivering sustainable and superior returns to our shareholders and investors. It is essential that we maintain the support of our shareholders and investors to enable access to capital. This allows us to implement our strategy and achieve our business objectives.
As adjusted for Canada.
We believe the greatest contribution we can make to society is Building a Smokeless World and reducing the health impact of our business*†. We will do this by encouraging those who would otherwise continue to smoke cigarettes to switch completely to Smokeless alternatives*†. Achieving this, while working to reduce our impact on the environment, is central to delivering A Better Tomorrow™.
Based on the weight of evidence and assuming a complete switch from cigarette smoking. These products are not risk free and are addictive.
Products sold in the U.S., including Vuse, Velo, Grizzly, Kodiak, and Camel Snus, are subject to FDA regulation and no reduced-risk claims will be made as to these products without agency clearance.

